 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
In 2003, Eli Lilly and Company, which makes the Parkinson’s disease medication Permax (pergolide), released results from its “post-marketing surveillance” that revealed heart valve damage in a small number of patients. Subsequently, the FDA required Eli Lilly to carry the strongest warning label, the “black box,” about the increased risk on the Permax label. The warnings appear at the top of prescribing information and include the statement that deaths have been associated with the drug.
A study released by The New England Journal of Medicine in January 2007 showed that patients taking Permax have significantly higher risk of heart valve damage than if they had not chosen this form of therapy. The damage to the heart valve can lead to heart failure and sudden death. The study was conducted through more than 11,000 records of Parkinson’s disease patients in Britain. Patients taking Permax were seven times more likely to suffer from heart valve damage than the control group.
Parkinson’s disease is a complex neurological disorder first described as "the shaking palsy." Permax was approved by the FDA in December 1988.
If you think you have suffered any problems resulting from the use of Permax, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
